Literature DB >> 8833489

Long-term outcome of coronary abnormalities in patients after Kawasaki disease.

J Fukushige1, N Takahashi, K Ueda, T Hijii, H Igarashi, A Ohshima.   

Abstract

From January 1973 through December 1992, a total of 302 patients (183 males, 119 females) with Kawasaki disease (KD) underwent coronary angiography. The age at onset of KD ranged from 2 months to 12.3 years (median 1.4 years). The age at the first angiographic evaluation ranged from 6 months to 17 years (median 3.5 years). Most of the patients (85%) had suffered from KD before 1985 and thus were treated without benefit of gamma-globulin. Follow-up varied from 6 months to 25.8 years (median 13.6 years). Coronary abnormalities were confirmed in 71 (23.5%) of 302 patients; the left coronary artery (LCA) alone was involved in 36 cases, the right coronary artery (RCA) alone in 10 cases, and both arteries in 25 cases. Serial angiographic evaluation of the 42 cases revealed different attitudes in the progress of coronary abnormalities. All large aneurysms showed a tendency to regress, although some progressed to stenotic lesions. Moderate aneurysms stayed unchanged, regressed, or progressed to stenosis or obstruction. Small aneurysm never became stenotic and frequently regressed to normal internal diameter. Aneurysms of the RCA tended to regress relatively early during the follow-up period, whereas those of the LCA gradually progressed to stenotic lesions. In 7 of 35 patients with RCA lesions, aneurysms progressed to complete obstruction and subsequent recanalization within 0.5 to 7.7 years (median 3.6 years) after the onset of KD. Most of the patients with coronary artery sequelae after KD remain asymptomatic. Serial angiographic observation is indicated for those patients who develop large coronary aneurysms during the acute phase of KD. The standard 12-lead electrocardiogram, chest roentgenogram, and exercise stress test are less sensitive for detecting and evaluating patients with coronary sequelae. For the screening of myocardial ischemia after KD, stress thallium 201 scintigraphy with dipyridamole infusion is recommended.

Entities:  

Mesh:

Year:  1996        PMID: 8833489     DOI: 10.1007/BF02505086

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  18 in total

1.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

2.  Detection of coronary artery stenosis in children with Kawasaki disease. Usefulness of pharmacologic stress 201Tl myocardial tomography.

Authors:  C Kondo; M Hiroe; T Nakanishi; A Takao
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

3.  Kawasaki disease: cardiac problems and management.

Authors:  H Kato; O Inoue; T Akagi
Journal:  Pediatr Rev       Date:  1988-01

4.  Coronary revascularization in a child with Kawasaki disease: use of right gastroepiploic artery.

Authors:  Y Takeuchi; A Gomi; Y Okamura; H Mori; M Nagashima
Journal:  Ann Thorac Surg       Date:  1990-08       Impact factor: 4.330

5.  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.

Authors:  J W Newburger; M Takahashi; A S Beiser; J C Burns; J Bastian; K J Chung; S D Colan; C E Duffy; D R Fulton; M P Glode
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

6.  Regression of aneurysms in Kawasaki disease: a pathological study.

Authors:  Y Sasaguri; H Kato
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

7.  Spectrum of cardiovascular lesions in mucocutaneous lymph node syndrome: analysis of eight cases.

Authors:  J Fukushige; M R Nihill; D G McNamara
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

8.  Altered lipid profile after Kawasaki syndrome.

Authors:  J W Newburger; J C Burns; A S Beiser; J Loscalzo
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

9.  Outcome of coronary artery aneurysms after Kawasaki disease.

Authors:  T Akagi; V Rose; L N Benson; A Newman; R M Freedom
Journal:  J Pediatr       Date:  1992-11       Impact factor: 4.406

10.  Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases.

Authors:  A Suzuki; T Kamiya; N Kuwahara; Y Ono; T Kohata; O Takahashi; K Kimura; M Takamiya
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

View more
  8 in total

1.  Kawasaki disease.

Authors:  S Saraf; R K Singh
Journal:  Indian J Pediatr       Date:  2001-10       Impact factor: 1.967

2.  Kawasaki disease--Indian perspective.

Authors:  R N Pendse; H Bhandari; A K Vats; B Bhandari
Journal:  Indian J Pediatr       Date:  2001-08       Impact factor: 1.967

3.  Kawasaki disease: a review with emphasis on cardiovascular complications.

Authors:  Ricardo Duarte; Silvia Cisneros; Gabriel Fernandez; Daniel Castellon; Cesar Cattani; Cíntia A Melo; Asier Apocada
Journal:  Insights Imaging       Date:  2010-07-30

4.  Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study.

Authors:  Jan Marc Orenstein; Stanford T Shulman; Linda M Fox; Susan C Baker; Masato Takahashi; Tricia R Bhatti; Pierre A Russo; Gary W Mierau; Jean Pierre de Chadarévian; Elizabeth J Perlman; Cynthia Trevenen; Alexandre T Rotta; Mitra B Kalelkar; Anne H Rowley
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

5.  Upregulated Expression of IL2RB Causes Disorder of Immune Microenvironment in Patients with Kawasaki Disease.

Authors:  Yunfei Liao; Ben Ke; Xiaoyan Long; Jianjun Xu; Yongbing Wu
Journal:  Biomed Res Int       Date:  2022-07-25       Impact factor: 3.246

6.  The Predictive Values of MMP-9, PLTs, ESR, and CRP Levels in Kawasaki Disease with Cardiovascular Injury.

Authors:  Yinan Yang; Xiaobin Hu
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-14       Impact factor: 2.650

7.  Nuclear Imaging in Pediatric Cardiology: Principles and Applications.

Authors:  Maelys Venet; Mark K Friedberg; Luc Mertens; Jerome Baranger; Zakaria Jalal; Ghoufrane Tlili; Olivier Villemain
Journal:  Front Pediatr       Date:  2022-07-06       Impact factor: 3.569

8.  Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease.

Authors:  Hyejin Jang; Kyu Yeun Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.